The Journal of Clinical and Translational Science (JCTS) announced today that Lars Berglund of UC Davis Health will be their new editor-in-chief, starting January 1, 2020.
Berglund is the associate vice chancellor for biomedical research and the vice dean for research for the UC Davis School of Medicine. He is an emeritus director of the UC Davis Clinical and Translational Science Center (CTSC). Berglund served as the interim dean for the UC Davis School of Medicine from 2017-2019.
“I am honored by the trust placed in me by the Board of the Journal of Clinical and Translational Science to serve as the next Editor-in-Chief,” Berglund said. “I very much look forward to working with the Board, the publisher Cambridge University Press and with the entire translational community.”
JCTS is the official journal of the Association of Clinical and Translational Science (ACTS). Its mission is to provide a forum for disseminating advances in clinical and translational science. JCTS is an open access journal publishing high-quality articles on research that informs the development of the translational workforce. The journal’s interest includes investigations into how to best develop processes and people that translate discoveries into improved health.